Drug Shortage Report for TARO-WARFARIN
Report ID | 38335 |
Drug Identification Number | 02242680 |
Brand name | TARO-WARFARIN |
Common or Proper name | TARO WARFARIN |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | WARFARIN SODIUM |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 250'S |
ATC code | B01AA |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-02-01 |
Estimated end date | 2018-03-01 |
Actual end date | 2018-02-08 |
Shortage status | Resolved |
Updated date | 2018-02-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-02-09 | French | Compare |
v3 | 2018-02-09 | English | Compare |
v2 | 2018-02-02 | French | Compare |
v1 | 2018-02-02 | English | Compare |
Showing 1 to 4 of 4